資料載入中.....
|
請使用永久網址來引用或連結此文件:
http://ir.cmu.edu.tw/ir/handle/310903500/29612
|
| 題名: | Disabled-2 is a negative regulator of integrin alpha(IIb)beta(3)-mediated fibrinogen adhesion and cell signaling |
| 作者: | Huang, CL;Cheng, JC;Liao, CH;Stern, A;Hsieh, JT;Wang, CH;Hsu, HL;Tseng, CP |
| 貢獻者: | 健康照護學院醫技系;Chang Gung Univ, Grad Inst Med Biotechnol, Tao Yuan 333, Taiwan;Chang Gung Univ, Grad Inst Nat Prod, Tao Yuan 333, Taiwan;China Med Univ, Dept Med Technol, Taichung 404, Taiwan;NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA;Univ Texas, SW Med Ctr, Dept Urol, Dallas, TX 75390 USA;Kaohsiung Med Univ, Fac Biotechnol, Kaohsiung 807, Taiwan |
| 日期: | 2004 |
| 上傳時間: | 2010-09-24 14:38:50 (UTC+8) |
| 出版者: | AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC |
| 摘要: | Purpose: This study aimed to correlate and compare the predictive values of rectal and bladder reference doses of uniform external beam radiotherapy without shielding and high-dose-rate intracavitary brachytherapy (HDRICB) with late sequelae in patients with uterine cervical cancer. Methods and Materials: Between September 1992 and December 1998, 154 patients who survived more than 12 months after treatment were studied. Initially, they were treated with 10-MV X-rays (44 to 45 Gy/22 to 25 fractions over 4 to 5 weeks) to the whole pelvis, after which HDRICB was performed using Ir-192 remote afterloading at 1-week intervals for 4 weeks. The standard prescribed dose for each HDRICB was 6.0 Gy to point A. Patient- and treatment-related-factors were evaluated for late rectal complications using logistic regression modeling. Results: The probability of rectal complications showed better correlation of dose-response with increasing total ICRU (International Committee on Radiotherapy Units and Measurements) rectal dose. Multivariate logistic regression demonstrated a high risk of late rectal sequelae in patients who developed rectal complications (p = 0.0001;relative risk, 15.06;95% CI, 2.89-43.7) and total ICRU rectal dose greater than 16 Gy (p = 0.02;relative risk, 2.07;95% CI, 1.13-4.55). The high risk factors for bladder complications were seen in patients who developed rectal complications (p = 0.0001;relative risk, 15.2;95% CI, 2.81similar to44.9) and total ICRU bladder dose greater than 24 Gy (p = 0.02;relative risk, 8.93;95% CI, 1.79similar to33.1). Conclusion: This study demonstrated the predictive value of ICRU rectal and bladder reference dosing in HDRICB for patients receiving uniform external beam radiation therapy without central shielding. Patients who had a total ICRU rectal dose greater than 16 Gy, or a total ICRU bladder dose over 24 Gy, were at risk of late sequelae. (C) 2004 Elsevier Inc. |
| 關聯: | JOURNAL OF BIOLOGICAL CHEMISTRY 279(40):42279-42289 |
| 顯示於類別: | [醫學檢驗生物技術學系暨碩士班 ] 期刊論文
|
在CMUR中所有的資料項目都受到原著作權保護.
|
